Get started
Author

Marina N. Rosanu

Observed names: M.N. Rosanu, Marina Nelia Rosanu, Marina Rosanu, N.M. Rosanu, Nelia Marina Rosanu, Rosanu, Marina
ORCID: 0009-0002-8949-6286
Observed ORCID: 0009-0002-8949-6286
OpenAlex ID: A5094110810
The prognostic impact of molecular classification in endometrial cancer that undergoes fertility-sparing treatment
2025 · Luigi A. De Vitis, Gabriella Schivardi, et al. · International Journal of Gynecological Cancer · 22
Navigating the clinical challenges of zolbetuximab in patients with claudin positive advanced gastric cancer
2025 · N.M. Rosanu, L. Gervaso, et al. · European Journal of Cancer · 9
Surgical complexity and scope of procedures necessary after neoadjuvant chemotherapy for primary ovarian cancer
2025 · Chiara Ainio, Marina Rosanu, et al. · Gynecologic Oncology · 5
Predictors of recurrence in early-stage cervical cancer without adjuvant treatment after radical surgery
2025 · Giuseppe Caruso, Michela Gaiano, et al. · European Journal of Surgical Oncology · 5
Para-aortic lymph node recurrence in surgically treated early-stage cervical cancer without para-aortic lymph node surgical staging
2024 · Tullio Golia D'Augè, Giuseppe Caruso, et al. · International Journal of Gynecological Cancer · 4
Diagnostic and Therapeutic Challenges Related to HER2 Heterogeneity in Gastric Cancer: Bridging Molecular Pathology and Clinical Decision-Making
2026 · Nelia Marina Rosanu, Lorenzo Gervaso, et al. · International Journal of Molecular Sciences · 2
PDF
Deep Learning for Decision Support in Ovarian Cancer Treatment Planning
2025 · Francesca Fati, Marina Rosanu, et al. · Research Square · 2
PDF
1252 Update on the role of intraoperative indocyanine green fluorescence angiography in preventing anastomotic leakage after colorectal resection in cytoreductive surgery for advanced ovarian cancer
2024 · Livia Xhindoli, Gabriella Schivardi, et al. · International Journal of Gynecological Cancer · 2
Impact of neoadjuvant chemotherapy on homologous recombination deficiency test results in patients with advanced high-grade serous ovarian cancer
2026 · Ilaria Betella, Diletta Fumagalli, et al. · International Journal of Gynecological Cancer · 1
Lymphadenectomy in early-stage ovarian cancer: is there still a role?
2026 · Giuseppe Caruso, Susanna Delfrati, et al. · International Journal of Gynecological Cancer · 1
Evolution of treatment strategies for advanced epithelial ovarian cancer: a 16-year overview from a referral center
2026 · Lucia Ribero, Diletta Fumagalli, et al. · International Journal of Gynecological Cancer
High Grade Adverse Events With Immune Checkpoint Inhibitors +/- Parp Inhibitors in Primary Advanced/recurrent Endometrial Cancer: a Systematic Review and Meta-analysis
2026 · Helena Obermair, Mariana Gouveia, et al. · International Journal of Gynecological Cancer
Is the New Portec-4a/esgo-estro-esp-adapted Algorithm Prognostic in a Real-world Population?
2026 · Lucia Ribero, Gabriella Schivardi, et al. · International Journal of Gynecological Cancer
Early-stage No-specific Molecular Profile (nsmp) Endometrial Cancer: Clinicopathological and Molecular Predictors of Recurrence
2026 · Lucia Ribero, Diletta Fumagalli, et al. · International Journal of Gynecological Cancer
Legal Frameworks, Institutional Barriers and Unmet Needs of Young University Students With Cancer in Italy: A Call to Action
2026 · Angela Toss, Laura Marziali, et al. · Cancer Medicine
PDF
Predicting Response to Neoadjuvant Chemotherapy in Ovarian Cancer from CT Baseline Using Multi-Loss Deep Learning
2026 · Francesco Pastori, Francesca Fati, et al. · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany
PDF
Incremental risk of high-grade adverse events with immune checkpoint inhibitors with or without poly(adenosine diphosphate-ribose) polymerase inhibitors in first-line treatment of advanced endometrial cancer: a systematic review and meta-analysis
2026 · Mariana Carvalho Gouveia, Helena M. Obermair, et al. · International Journal of Gynecological Cancer
Predicting residual disease and extent of surgery after neoadjuvant chemotherapy for ovarian cancer: Does the MSKCC model from the primary setting apply?
2026 · Chiara Ainio, Giuseppe Caruso, et al. · Gynecologic Oncology
Impact of indocyanine green fluorescence angiography on anastomotic leak in ovarian cancer cytoreductive surgery: a retrospective cohort study
2026 · Gabriella Schivardi, Lucia Ribero, et al. · International Journal of Gynecological Cancer
Management of cancer-associated thrombosis in patients with gastrointestinal cancers: lights and shadows
2026 · Lorenzo Gervaso, Eleonora Cioli, et al. · Cancer Treatment Reviews
Three-Dimensional Deep Learning Prediction of Cytoreduction Outcome Using Preoperative CT Scans: A Preliminary Internal Validation Study
2026 · Roberto Veraldi, Marina N. Rosanu, et al. · International Journal of Gynecological Cancer
Evidence-Based Text-Conditioned 3D CT Synthesis for Ovarian Cancer
2026 · Panaccione, Francesca Pia, Lomurno, Eugenio, et al. · arXiv (Cornell University)
PDF
Correction: Training European Health Care Providers in Adolescent and Young Adult (AYA) Oncology: The Joint Action Networks of Expertise (JANE) on AYA with Cancer Perspective
2026 · Virginia Livellara, Marina N. Rosanu, et al. · Journal of Cancer Education
PDF
Training European Health Care Providers in Adolescent and Young Adult (AYA) Oncology: The Joint Action Networks of Expertise (JANE) on AYA with Cancer Perspective
2026 · Virginia Livellara, Marina N. Rosanu, et al. · Journal of Cancer Education
PDF
Vision Transformers for Preoperative CT-Based Prediction of Histopathologic Chemotherapy Response Score in High-Grade Serous Ovarian Carcinoma
2026 · Fati, Francesca, Coutinho, Felipe, et al. · arXiv (Cornell University)
PDF
Works count: 50
Citation count: 53
H-index: 4
I10-index: 1
Year
Topic
Type